OTCMKTS:BIOQ

Bioqual Stock Forecast, Price & News

$87.00

0.00 (0.00 %)

(As of 04/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$87.00

Now: $87.00▼

$87.00

50-Day Range

$85.00

MA: $86.77▼

$88.00

52-Week Range

$50.00

Now: $87.00▼

$92.00

VolumeN/A

Average Volume383 shs

Market Capitalization$77.43 million

P/E Ratio16.60

Dividend Yield1.26%

Beta-0.33

Bioqual, Inc. provides research, development, pre-clinical, and testing/assay services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides in-vivo animal model services related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Commercial physical research

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:BIOQ

Previous Symbol

CUSIP09065J101

CIK719711

Webwww.bioqual.com

Phone240-404-7654

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio16.60

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$46.36 million

Price / Sales1.67

Cash Flow$4.39 per share

Price / Cash Flow19.81

Book Value$27.46 per share

Price / Book3.17

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$4.23 million

Net Margins9.12%

Return on Equity17.62%

Return on Assets9.81%

Miscellaneous

Outstanding Shares890,000

Market Cap$77.43 million

Next Earnings Date4/20/2021 (Estimated)

OptionableNot Optionable

Headlines

Bioqual, Inc. (OTCMKTS:BIOQ) Short Interest Up 100.0% in March
March 29, 2021 | americanbankingnews.com

BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2020
January 27, 2020 | finance.yahoo.com

BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2020
December 26, 2019 | finance.yahoo.com

BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2019
September 3, 2019 | finance.yahoo.com

BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2019
September 3, 2019 | finance.yahoo.com

BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2019
September 3, 2019 | finance.yahoo.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.94 out of 5 stars

Medical Sector

1116th out of 2,021 stocks

Commercial Physical Research Industry

19th out of 42 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Bioqual.

2.6 Community Rank

Outperform Votes
Bioqual has received 106 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Bioqual has received 97 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Bioqual has received 52.22% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Bioqual and other stocks. Vote “Outperform” if you believe BIOQ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BIOQ will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Bioqual has a dividend yield of 1.26%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Bioqual does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bioqual insiders have not sold or bought any company stock.
Percentage Held by Insiders
39.24% of the stock of Bioqual is held by insiders. A high percentage of insider ownership can be a sign of company health.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Bioqual is 16.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.91.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bioqual is 16.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 44.57.
Price to Book Value per Share Ratio
Bioqual has a P/B Ratio of 3.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

$87.00

0.00 (0.00 %)

(As of 04/15/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive BIOQ News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOQ and its competitors with MarketBeat's FREE daily newsletter.

Bioqual (OTCMKTS:BIOQ) Frequently Asked Questions

What stocks does MarketBeat like better than Bioqual?

Wall Street analysts have given Bioqual a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Bioqual wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Bioqual?

Bioqual saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 200 shares, an increase of 100.0% from the February 28th total of 100 shares. Based on an average daily volume of 400 shares, the days-to-cover ratio is presently 0.5 days.
View Bioqual's Short Interest.

When is Bioqual's next earnings date?

Bioqual is scheduled to release its next quarterly earnings announcement on Tuesday, April 20th 2021.
View our earnings forecast for Bioqual.

How were Bioqual's earnings last quarter?

Bioqual, Inc. (OTCMKTS:BIOQ) issued its quarterly earnings results on Friday, January, 22nd. The company reported $1.63 earnings per share (EPS) for the quarter. The business had revenue of $13.57 million for the quarter. Bioqual had a net margin of 9.12% and a trailing twelve-month return on equity of 17.62%.
View Bioqual's earnings history.

How has Bioqual's stock price been impacted by COVID-19?

Bioqual's stock was trading at $51.75 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BIOQ stock has increased by 68.1% and is now trading at $87.00.
View which stocks have been most impacted by COVID-19.

How often does Bioqual pay dividends? What is the dividend yield for Bioqual?

Bioqual declared an annual dividend on Tuesday, September 15th. Investors of record on Monday, September 28th will be paid a dividend of $1.10 per share on Wednesday, October 21st. This represents a dividend yield of 1.62%. The ex-dividend date is Friday, September 25th. This is a boost from Bioqual's previous annual dividend of $0.70.
View Bioqual's dividend history.

Is Bioqual a good dividend stock?

Bioqual pays an annual dividend of $1.10 per share and currently has a dividend yield of 1.26%.
View Bioqual's dividend history.

Who are Bioqual's key executives?

Bioqual's management team includes the following people:

Dr. David A. Newcomer, Chief Financial Officer (Age 60, Pay $123.78k)
Dr. Marisa St. Claire DVM, VP - Primate Biology and Medicine (Age 56, Pay $103k)
Dr. Mark G. Lewis, Chairman, CEO & Pres (Age 66)
Mitch Franklin, Chief Operating Officer
Nancy A. Madden, VP of Admin. Operations & Biosafety Officer
Dr. J. Thomas August, Consultant, Scientific Adviser and Director (Age 93)

Who are some of Bioqual's key competitors?

Some companies that are related to Bioqual include Bioanalytical Systems (BASI), Auxly Cannabis Group (CBWTF), Pieris Pharmaceuticals (PIRS), Eloxx Pharmaceuticals (ELOX), Cleveland BioLabs (CBLI), ProMIS Neurosciences (ARFXF), NanoViricides (NNVC), AIkido Pharma (AIKI), Inhibitor Therapeutics (INTI), HedgePath Pharmaceuticals (HPPI), Tenax Therapeutics (TENX), U.S. Stem Cell (USRM), Vitality Biopharma (VBIO), DNAPrint Genomics (DNAG) and Protalex (PRTX).
View all of BIOQ's competitors.

What is Bioqual's stock symbol?

Bioqual trades on the OTCMKTS under the ticker symbol "BIOQ."

How do I buy shares of Bioqual?

Shares of BIOQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bioqual's stock price today?

One share of BIOQ stock can currently be purchased for approximately $87.00.

How much money does Bioqual make?

Bioqual has a market capitalization of $77.43 million and generates $46.36 million in revenue each year.

What is Bioqual's official website?

The official website for Bioqual is www.bioqual.com.

Where are Bioqual's headquarters?

Bioqual is headquartered at 9600 Medical Center Drive Suite 101, ROCKVILLE MD, 20850.

How can I contact Bioqual?

Bioqual's mailing address is 9600 Medical Center Drive Suite 101, ROCKVILLE MD, 20850. The company can be reached via phone at 240-404-7654 or via email at [email protected]

This page was last updated on 4/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here